Announcements Trials

Browse Landscape

Phase

Status

Recruiting 7 Active not recruiting 7 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 1

Interventions

pembrolizumab 74 Cyclophosphamide 50 Cisplatin 46 Nivolumab 36 Radiotherapy 33 Paclitaxel 33 Carboplatin 31 Gemcitabine 30 Docetaxel 27 Dexamethasone 24 atezolizumab 23 Doxorubicin 21 Bevacizumab 21 Etoposide 20 Blood Specimen Collection 20 Vincristine 18 Magnetic Resonance Spectroscopy 18 Leucovorin 18 Lenalidomide 18 Fluorouracil 18 fludarabine 17 Rituximab 17 Radiosurgery 17 Surveys and Questionnaires 16 Oxaliplatin 16 Cytarabine 16 Radiation 15 Ipilimumab 15 palbociclib 14 durvalumab 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × belzutifan × 90 days × Clear all

NCT04846920 2026-05-22

MK-6482-018

Merck Sharp & Dohme LLC

Phase 1 Completed

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡